| Lab
Spotlight: Brookhaven National Laboratory
Pet
Scans Show Brain Responses to Light, Electrical Stimulation
A study measuring
metabolic changes in the brains of sighted people is showing
similar responses to both light and electrical stimulations. Researchers
at the U.S. Department of Energy’s Brookhaven National Laboratory,
Doheny Eye Institute at the University of Southern California,
and Columbia University now are taking this study a step further
to demonstrate that the visual cortex in patients with retinitis
pigmentosa (RP) can respond to electrical stimulation.
Using positron emission
tomography (PET) scanning and a glucose analogue called FDG, the
researchers evaluated and compared what happens to the visual
processing part of the brain following different stimuli. Eight
healthy volunteers with normal vision participated in the study.
Each underwent three PET scans on three different days to represent
baseline conditions, responses to light stimulation, and responses
to electrical stimulation.
|
| Pet
scans showing brain activity in response to light (upper)
stimulation and electrical (lower) stimulation. Click on
image to enlarge. |
Prior to each scan,
the volunteers sat quietly in a darkened room for 30 minutes to
dark adapt before receiving the FDG injection. For the baseline
scan, both eyes were blindfolded. During the light stimulation
scan, the person’s right eye was exposed to light flashes
from a computer monitor. For the electrical stimulation experiment,
a fiber electrode was placed on the right eye and a stream of
electrical pulses with the same duty cycle was delivered. The
results show similar activation and inactivation patterns between
the light and electrical stimulations.
Extending the study
to RP patients implanted with retinal prostheses, the researchers
will analyze what happens to the visual part of the brain over
time as the device is used more by patients. Ultimately, the researchers
hope to use the results to examine the effect of cortical reorganization
in retinal degenerative diseases.
The original work was
funded by the U.S. Department of Energy, and the RP patient work
is being funded by the National Science Foundation (NSF grant
number: 0917458).
|